Company news

hVIVO plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Schedule One Update

January 16, 2020

Second Closing of the Offer

January 14, 2020

Director's Dealings

January 8, 2020

Publication and Posting of Rule 15 Proposals

January 7, 2020

Proposed cancellation of trading on AIM

January 6, 2020

Offer Update

December 31, 2019

HVIVO PLC

December 19, 2019

New Contract with SFA Therapeutics

December 18, 2019

Recommended Merger of hVIVO with Open Orphan

December 9, 2019

Early adopters signed for Genomic Health DataBANK

November 25, 2019

Contract signed with Carna Bioscience

November 18, 2019

Jefferies 2019 London Healthcare Conference

November 15, 2019

Preferred Partner Agreement

November 11, 2019

Agreement signed with Empiric Logic

October 15, 2019

hVIVO to present at ERS International Congress

September 27, 2019

Interim Results for 6 months ended 30 June 2019

September 25, 2019

Interim Results 2019

September 19, 2019

Notice of Interim Results

August 23, 2019

Successful RSV Challenge Study in Older Adults

August 6, 2019

Directorate Changes

August 1, 2019

Phase 1 clinical trial of AGS-v PLUS

July 31, 2019

Integumen Shares

July 12, 2019

First Day of Dealings and Re-admission

June 28, 2019

Directorate Update

June 25, 2019

RSV Challenge Model Delivers Positive Results

June 17, 2019

Euronext Growth - Schedule One

June 14, 2019

Placing of Shares

June 11, 2019

Conditional Acquisition of Open Orphan DAC

May 10, 2019

Integumen Debt Conversion

May 1, 2019

2018 Annual Report and Financial Statements

April 26, 2019

Preliminary Results 2018

April 11, 2019

Financing Update

April 8, 2019

hVIVO and Imutex to present at IVW 2019

March 29, 2019

Change of Adviser

March 26, 2019

Notice of Preliminary Results

March 8, 2019

Share Incentive Plan and PDMR Dealings

January 24, 2019

Partnership Announcement

January 18, 2019

Positive data for Phase IIb FLU-v challenge study

January 10, 2019

Award of Share Options

January 4, 2019

Strategic Collaboration Agreement and Financing

December 11, 2018

Trading Update and Change of Adviser

November 8, 2018

Partial preliminary results for NIH study of AGS-v

October 31, 2018

Two new contracts for RSV human challenge studies

October 8, 2018

Notification of Major Holdings

October 1, 2018

Notification of Major Interest in Shares

September 10, 2018

Placing & Subscription to raise up to £0.65m

July 4, 2018

Positive Results for Phase IIb FLU-v Field Study

June 18, 2018

Notice of AGM & Posting of Annual Report&Accounts

June 6, 2018

Final Results

May 17, 2018

2017 Annual Report and Financial Statements

April 27, 2018

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.